Chiron Corporation

Aviron

Medimmune Vaccines, Inc.

The Director General of the National Institute of Health of Japan

Tai-An Cha

Richard R Spaete

Janice A Kolberg

Bruce D Irvine

Michael S Urdea

Eileen Beall

Michael Houghton

Tatsuo Miyamura

Amy J Weiner

Jang Hyun Han

Izumi Saito

Provided are novel Toledo and Towne human cytomegalovirus DNA sequences (HCMV) and proteins encoded thereby. The sequences are useful in methods and compositions for detecting HCMV infections and in immunogenic compositions for Preventing HCMV infections.

Human cytomegalovirus DNA sequences

Provided are novel Toledo and Towne human cytomegalovirus DNA sequences (HCMV) and proteins encoded thereby. The sequences are useful in methods and compositions for detecting HCMV infections and in immunogenic compositions for preventing HCMV infections.

The present application features nucleic acid, peptide and antibody compositions relating to genotypes of hepatitis C virus and methods of using such compositions for diagnostic and therapeutic purposes.

HCV genomic sequences for diagnostics and therapeutics

Provided are novel Toledo and Towne Human cytomegalovirus DNA sequences (HCMV) and proteins encoded thereby. The sequences are useful in methods and compositions for detecting HCMV infections and in immunogenic compositions for preventing HCMV infections.

Two new isolates of the Hepatitis C virus (HCV), J1 and J7, are disclosed. These new isolates comprise nucleotide and amino acid sequences which are distinct from the prototype HCV isolate, HCV1. Thus, J1 and J7 provide new polynucleotides and polypeptides for use, inter alia, in diagnostics, recombinant protein production and vaccine development.

Growing community of inventors

San Ramon, CA, United States of America

Tai-An Cha